Detalhe da pesquisa
1.
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38800943
2.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38804599
3.
Patterns of interventions for central venous catheter-associated deep vein thrombosis and outcomes in cancer patients.
J Oncol Pharm Pract
; : 10781552231219995, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166462
4.
The interplay of membrane fluidity, acyl chain order and area per lipid on the partitioning of two antidepressants paroxetine and sertraline.
Soft Matter
; 19(29): 5527-5537, 2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435937
5.
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients.
Acta Haematol
; 146(6): 538-542, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708871
6.
Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience.
Acta Haematol
; 146(6): 490-495, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156364
7.
A Multicenter Study of Clinicopathology and Immunohistochemical Distinction between Adult and Pediatric Large B-Cell Lymphoma.
Fetal Pediatr Pathol
; 42(3): 355-366, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106665
8.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Cancer
; 128(3): 529-535, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633671
9.
Adapting a Dehazing System to Haze Conditions by Piece-Wisely Linearizing a Depth Estimator.
Sensors (Basel)
; 22(5)2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271107
10.
A Clinical Review of Biosimilars Approved in Oncology.
Ann Pharmacother
; 55(3): 362-377, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715722
11.
Haziness Degree Evaluator: A Knowledge-Driven Approach for Haze Density Estimation.
Sensors (Basel)
; 21(11)2021 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34200061
12.
Automating a Dehazing System by Self-Calibrating on Haze Conditions.
Sensors (Basel)
; 21(19)2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34640693
13.
Visibility Restoration: A Systematic Review and Meta-Analysis.
Sensors (Basel)
; 21(8)2021 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33918021
14.
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Am J Hematol
; 95(10): 1193-1199, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628327
15.
Single-Image Visibility Restoration: A Machine Learning Approach and Its 4K-Capable Hardware Accelerator.
Sensors (Basel)
; 20(20)2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066285
16.
Single Image Haze Removal from Image Enhancement Perspective for Real-Time Vision-Based Systems.
Sensors (Basel)
; 20(18)2020 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32927812
17.
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Br J Haematol
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38808512
18.
Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.
J Oncol Pharm Pract
; 25(8): 2027-2030, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537919
19.
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia.
Br J Haematol
; 196(6): e71-e74, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931310
20.
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Am J Hematol
; 96(6): E196-E200, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719090